Stay updated on Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial record for the pembrolizumab-versus-placebo study is now accessible, with details on its completed status, results, study design, eligibility criteria, outcomes, and locations.
    Difference
    100%
    Check dated 2026-11-08T04:49:44.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T01:54:13.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates and FAQs about the transition from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-25T01:55:51.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T01:44:59.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:14:06.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details with an error page and leaving only a basic header/navigation.
    Difference
    19%
    Check dated 2026-09-20T01:00:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in HCC Adjuvant Therapy Clinical Trial page.